![Mark Plavsic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Plavsic
Technik-/Wissenschafts-/F&E-Leiter bei
AURA BIOSCIENCES, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Dr. Mark Plavsic ist ein Chief Technical Officer bei Fate Therapeutics, Inc. Dr. Plavsic war zuvor als Chief Technical Officer bei Lysogene SA und als Head- Process Development & Manufacturing bei Torque Therapeutics, Inc. beschäftigt. Er erhielt seinen Abschluss an der Universität von Belgrad und promovierte an der Universität von Belgrad.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,39 % | 02.03.2026 | 243.736 ( 0,39 % ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Mark Plavsic
| Unternehmen | Position | Beginn |
|---|---|---|
| AURA BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.10.2023 |
TeraPore Technologies, Inc.
 TeraPore Technologies, Inc. Chemicals: SpecialtyProcess Industries Manufactures and distributes filters for protein separations | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Mark Plavsic
| Unternehmen | Position | Ende |
|---|---|---|
| FATE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 06.03.2023 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Corporate Officer/Principal | - |
| LYSOGENE | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Mark Plavsic
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
University of Belgrade
 University of Belgrade Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Health Technology |
TeraPore Technologies, Inc.
TeraPore Technologies, Inc. Chemicals: SpecialtyProcess Industries Manufactures and distributes filters for protein separations | Process Industries |
